CONTENTS
Preface = ix
1. Background information and programme considerations = 1
Development of injectable contraceptives = 1
Formulation and mode of action = 2
Role of injectable contraceptives in family planning programmes = 3
Controversy associated with injectable contraceptive = 4
Factors affecting availability and acceptance = 8
Factors affecting programmes = 15
Additional sources of information = 2
2. Injectables and the health system = 23
Service delivery channels = 23
Follow-up and referral facilities = 26
Supervision of service delivery personnel = 27
Additional source of information = 28
3. Organizing and managing a Programme offering injectable contraceptives = 29
Check-list for use in planning services = 29
Identifying potential obstacles = 29
Facilities = 31
Supplies = 37
Requirements forecasting = 39
Order frequency = 44
Order quantities = 44
Minimum stock levels and order points = 45
Supply requirements = 47
Storage of supplies = 48
Distribution systems = 50
Shelf-life and quality control = 51
Record-keeping = 52
Staffing = 52
Financing = 52
Characteristics of successful programmes = 53
Additional sources of information = 54
4. Information, education and communication = 55
Counselling = 55
Other audiences for the IEC programme = 58
Provision of IEC = 59
Assessment of information needs = 60
Channels of communication = 61
Special groups = 62
Summary = 64
5. Pretreatment care and administration = 65
Medical screening = 65
Medical history, physical examination and other investigations = 67
Special problems requiring medical assessment = 68
Recording of information = 71
Administration = 71
Additional sources of information = 73
6. Post-administration care = 74
Post-injection advice and care = 74
Special problems and their management = 74
Follow-up = 80
7. Training = 83
Objective = 83
Subjects covered = 83
Check-list = 86
Costs = 86
8. Evaluation = 87
Definition and purposes of evaluation = 87
The evaluation process = 88
Topic for evaluation and performance indicators = 89
Non-routine studies and surveys = 92
Additional sources of information = 94
9. Operational and other research = 95
Introductory trials = 95
Development of new injectable contraceptives = 98
Additional sources of information = 98
Annex 1. Countries and territories in which DMPA and NET-EN are registered = 100
Annex 2. International sources of technical and funding assistance for injectable contraceptive programmes = 102
Annex 3. Principal manufacturers of injectable contraceptives = 104
Annex 4. Calculation of the equilibrium level = 105
Annex 5. Additional indicators for evaluating injectable contraceptive services = 111
